Robert Huizinga
Tracked across 2 events · 13 articles · First seen May 29, 2026 · Last active Aug 05, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Robert Huizinga is the Interim CEO of Kane Biotech and is among the recipients of the stock options.
May 29, 2026 · 6 articles
Business
Impact: As Interim CEO, Robert Huizinga is focused on executing commercial objectives while evaluating strategic initiatives, playing a key role in the review process.
Aug 05, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Robert Huizinga live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard